Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C. de Kiviet"'
Autor:
B L, Aalbers, K M, de Winter-de Groot, H G M, Arets, R W, Hofland, A C, de Kiviet, M M M, van Oirschot-van de Ven, M A, Kruijswijk, S, Schotman, S, Michel, C K, van der Ent, H G M, Heijerman
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 19(4)
The first available CFTR modulator combination for homozygous F508del patients, lumacaftor/ivacaftor, has not been tested in patients with percentage predicted (pp)FEVIn this retrospective observational study, patients aged 6 years or older starting
Autor:
S. Schotman, M.A. Kruijswijk, H.G.M. Heijerman, Bente L. Aalbers, K.M. de Winter-de Groot, Bert Arets, Inez Bronsveld, C. de Kiviet, F. Mohammed Hoessein, S. Michel, Regina W. Hofland, M van de Ven, K. van der Ent
Publikováno v:
Journal of Cystic Fibrosis. 19:S115
Autor:
K.M. de Winter-de Groot, K. van der Ent, Bente L. Aalbers, Regina W. Hofland, S. Schotman, Inez Bronsveld, C. de Kiviet, M van de Ven, S. Michel, H.G.M. Heijerman, Bert Arets, M.A. Kruijswijk
Publikováno v:
Journal of Cystic Fibrosis. 19:S117
Publikováno v:
Journal of Cystic Fibrosis. 18:S43-S44
Publikováno v:
Journal of Cystic Fibrosis. 9
Background: Of the 377 adult patients at the regional Cystic Fibrosis (CF) Unit, Leeds, 166 (44%) have Totally Implantable Vascular Access Devices (TIVAD). For the remaining 211 (56%) requiring intravenous antibiotic therapy, peripheral longlines are